Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    Tight junction defects in patients with atopic dermatitis.
        
        J. Allergy Clin. Immunol. 127, 773-786 (2011)
    
    
    
				BACKGROUND: Atopic dermatitis (AD) is characterized by dry skin and a hyperactive immune response to allergens, 2 cardinal features that are caused in part by epidermal barrier defects. Tight junctions (TJs) reside immediately below the stratum corneum and regulate the selective permeability of the paracellular pathway. OBJECTIVE: We evaluated the expression/function of the TJ protein claudin-1 in epithelium from AD and nonatopic subjects and screened 2 American populations for single nucleotide polymorphisms in the claudin-1 gene (CLDN1). METHODS: Expression profiles of nonlesional epithelium from patients with extrinsic AD, nonatopic subjects, and patients with psoriasis were generated using Illumina's BeadChips. Dysregulated intercellular proteins were validated by means of tissue staining and quantitative PCR. Bioelectric properties of epithelium were measured in Ussing chambers. Functional relevance of claudin-1 was assessed by using a knockdown approach in primary human keratinocytes. Twenty-seven haplotype-tagging SNPs in CLDN1 were screened in 2 independent populations with AD. RESULTS: We observed strikingly reduced expression of the TJ proteins claudin-1 and claudin-23 only in patients with AD, which were validated at the mRNA and protein levels. Claudin-1 expression inversely correlated with T(H)2 biomarkers. We observed a remarkable impairment of the bioelectric barrier function in AD epidermis. In vitro we confirmed that silencing claudin-1 expression in human keratinocytes diminishes TJ function while enhancing keratinocyte proliferation. Finally, CLDN1 haplotype-tagging SNPs revealed associations with AD in 2 North American populations. CONCLUSION: Collectively, these data suggest that an impairment in tight junctions contributes to the barrier dysfunction and immune dysregulation observed in AD subjects and that this may be mediated in part by reductions in claudin-1.
			
			
		Impact Factor
					Scopus SNIP
					
					
					
					Altmetric
					
				0.000
					2.348
					
					
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
     
    
     
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2011
    
 
     
    
        HGF-Berichtsjahr
        0
    
 
    
    
        ISSN (print) / ISBN
        0091-6749
    
 
    
        e-ISSN
        1097-6825
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        The journal of allergy and clinical immunology
    
 
		
    
        Quellenangaben
        
	    Band: 127,  
	    Heft: 3,  
	    Seiten: 773-786 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
        
            Verlagsort
            Amsterdam [u.a.]
        
 
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Institute for Allergy Research (IAF)
    
 
     
     
     
     
     	
    
        PubMed ID
        21163515
    
    
    
        Erfassungsdatum
        2011-12-31